Owning the best lithium battery stock is the simple way to profit off the whole electric vehicle industry without having to guess which EV car company will win out.
The rise of electric vehicle stocks might have you thinking about names like Tesla Inc. (NASDAQ: TSLA) or Nio Inc. (NYSE: NIO) for profits. While these have delivered significant growth for investors over the last couple years, their best gains might be in the rearview.
Top 10 Heal Care Stocks To Invest In Right Now: Comp En De Mn Cemig ADS(CIG)
Companhia Energetica de Minas Gerais CEMIG, incorporated on May 22, 1952, is a Brazil-based holding company mainly engaged in the generation, transmission and distribution of electricity. The Company operates through the segments: Generation, Transmission, Distribution, Telecom, Gas and Other. As of December 31, 2014, the Company generated electricity at 78 hydroelectric plants, three thermoelectric plants and 23 wind farms, with total installed capacity of 7,716 Megawatts. Of this capacity, the hydroelectric plants had a total of 7,334 Megawatts, the thermal plants 184 Megawatts, and the wind farms 199 Megawatts. The Company’s electric power transmission business consists of transporting power from the facilities where it is generated to points of consumption, distribution networks and Free Consumers. The transmission network consists of power transmission lines and substations with voltage of 230 kilovolts or more.
The Company’s distribution operation consists of transfers of electricity from distribution substations to final consumers. It includes four public service electricity distribution concession contracts in the State of Minas Gerais, granting rights to commercial operation of services related to the supply of electricity to captive consumers in municipalities in its concession area, including consumers that may be eligible, under the legislation, to become Free Consumers. The concession area of Cemig Distribution covers approximately 219,103 square miles, or 96.7% of the territory of the State of Minas Gerais.
As of December 31, 2014, the Company’s electricity system consisted of 316,500 miles of distribution lines, through which it supplied 27,011 Gigawatt hour to 8.0 million captive consumers and transported 17,448 Gigawatt hour to 417 Free Consumers. As of December 31, 2014, the total volume of electricity distributed was 44,459 Gigawatt hour. The Company is also engaged in the following businesses: telecommunications, through its consolidated subsidiary Cemig T! elecomunicacoes S.A.; national and international energy solutions consulting business, through its subsidiary Efficientia S.A.; exploitation of natural gas, through five consortia, including Exploration Consortium SF-T-104, Exploration Consortium SF-T-114, Exploration Consortium SF-T-120, Exploration Consortium SF-T-127, and Exploration Consortium REC-T-163; sale and trading of electricity, through structuring and intermediation of purchase and sale transactions, trading electricity in the Free Market, through its wholly owned subsidiaries Cemig Trading S.A. and Empresa de Servicos de Comercializacao de Energia Eletrica S.A. and Cemig Comercializadora de Energia Incentivada S.A.; acquisition, transport and distribution of gas and its sub products and derivatives through Companhia de Gas de Minas Gerais (Gasmig), and technology systems and systems for operational management of public service concessions, including companies operating in electricity, gas, water and sewerage and other utility companies, through Axxiom Solucoes Tecnologicas S.A.
- [By Max Byerly]
CEMIG (NYSE:CIG) and Huaneng Power International (NYSE:HNP) are both mid-cap utilities companies, but which is the superior stock? We will contrast the two businesses based on the strength of their institutional ownership, valuation, analyst recommendations, dividends, earnings, risk and profitability.
- [By Rich Smith]
Shares of Brazilian electric utility Companhia Energetica de Minas Gerais (NYSE:CIG) gained 9.4% on the day.
Companhia de Saneamento Basico do Estado de Sao Paulo (NYSE:SBS), a Brazilian wastewater treatment company, closed 9.6% higher.
- [By Stephan Byrd]
CEMIG (NYSE:CIG) was the recipient of a significant growth in short interest during the month of June. As of June 15th, there was short interest totalling 10,718,816 shares, a growth of 174.6% from the May 31st total of 3,903,277 shares. Based on an average daily volume of 6,056,542 shares, the short-interest ratio is presently 1.8 days.
Top 10 Heal Care Stocks To Invest In Right Now: Activision Blizzard, Inc(ATVI)
Activision Blizzard, Inc. develops and publishes online, personal computer (PC), video game console, handheld, mobile, and tablet games worldwide. The company develops and publishes interactive entertainment software products through retail channels or digital downloads; and downloadable content to a range of gamers. It also publishes online subscription-based games in the massively multiplayer online role-playing game category; and real-time strategy and role-playing games. In addition, the company maintains a proprietary online-game related service, Battle.net that facilitates the creation of user generated content, digital distribution, and online social connectivity in its games. Further, it provides warehousing, logistical, and sales distribution services to third-party publishers of interactive entertainment software; and manufacturers of interactive entertainment hardware products. The company serves retailers and distributors, including mass-market retailers, consumer electronics stores, discount warehouses, game specialty stores, and consumers through third-party distribution, licensing arrangements, and direct digital purchases. Activision Blizzard, Inc. is headquartered in Santa Monica, California.
- [By ]
There are a number of ways you can take advantage of this promising industry. You could invest in the “big boys” like Electronic Arts (Nasdaq: EA), which makes popular franchises FIFA soccer, Madden NFL, Apex Legends, and the Star Wars series Battlefront. Then there’s Activision Blizzard (Nasdaq: ATVI) which produces games like World of Warcraft, Call of Duty, Candy Crush, and Overwatch.
- [By Motley Fool Staff]
For this episode, it’s time to check in on not one but two such samplers. First, it’s been one year since he offered up “Five Stocks I Own That You Should Too.” Those were Activision Blizzard(NASDAQ:ATVI), Alphabet(NASDAQ:GOOGL) (NASDAQ:GOOG),Intuitive Surgical(NASDAQ:ISRG), Match Group(NASDAQ:MTCH), and Zillow(NASDAQ:Z) (NASDAQ:ZG), and he’ll review their progress with senior analystJim Mueller.
- [By Keith Noonan]
The interactive entertainment industry is a large, fast-growing market that still has lots of potential.Companies that can continue adapting to — and shaping — the demands of that industry are poised to deliver great returns for shareholders. With that in mind,Take-Two Interactive (NASDAQ:TTWO),Tencent Holdings (NASDAQOTH:TCEHY), Activision Blizzard (NASDAQ:ATVI),Electronic Arts (NASDAQ:EA), andCapcom (NASDAQOTH:CCOEF)stand out as top gaming stocks for the long term.
Top 10 Heal Care Stocks To Invest In Right Now: Catalyst Biosciences, Inc. (CBIO)
Catalyst Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on engineering proteases as therapeutics for hemophilia, hemeostasis, complement-mediated diseases, and other unmet medical needs. Its product pipeline includes CB 813d, a Factor VIIa drug candidate that completed a Phase I clinical trials evaluating safety and tolerability, as well as pharmacokinetics, pharmacodynamics, and coagulation activity in severe hemophilia A and B patients with and without inhibitors. The companys preclinical development stage drugs comprise CB 2679d/ISU 304, a next-generation Factor IX drug for the treatment of patients with hemophilia B; and a Factor Xa variant. It is also developing CB 2782, an anti-C3 inflammation development candidate for the treatment of delayed graft function in kidney transplants; and an ophthalmic anti-C3 candidate for treatment of dry age-related macular degeneration. The company has collaboration agreement with Pfizer, Inc. for the development of human Factor VIIa products; and ISU Abxis for development and manufacturing of the Factor IX products through Phase I/II clinical trials. Catalyst Biosciences, Inc. is headquartered in South San Francisco, California.
- [By Ethan Ryder]
Get a free copy of the Zacks research report on Catalyst Biosciences (CBIO)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
- [By Chris Lange]
Catalyst Biosciences Inc. (NASDAQ: CBIO) is scheduled to present interim data from its Phase 2 study of Marzeptacog alfa (MarzAA) on July 18. This data will be pertaining to the subcutaneous efficacy trial in individuals with hemophilia A or B with inhibitors to evaluate the ability of MarzAA to minimize spontaneous bleeding episodes.
Top 10 Heal Care Stocks To Invest In Right Now: Chicopee Bancorp, Inc.(CBNK)
Chicopee Bancorp, Inc., incorporated on March 14, 2006, is a bank holding company. The Company provides a range of financial services to individuals and businesses through its bank subsidiary, Chicopee Savings Bank (the Bank). The Bank is a state-chartered savings bank operating over eight branch offices, and a lending and operation center in Western Massachusetts. The Banks’s business consists of making loans to its customers and investing in a range of investment securities. The Bank funds these lending and investment activities with deposits from the general public, funds generated from operations and borrowings. The Bank also provides access to insurance and investment products through its Financial Services Division. Through Linsco/Private Ledger (LPL), the Bank offers customers a range of non-deposit investment products, including mutual funds, debt, equity and government securities, retirement accounts, insurance products and fixed and variable annuities.
The Company originates one- to four-family real estate loans, commercial real estate loans, residential and commercial construction loans, commercial and industrial loans, home equity lines-of-credit, fixed rate home equity loans and other consumer loans under its lending activity. The Company’s total loan portfolio is approximately $585.7 million. The total residential real estate loan portfolio is over $127.6 million. It offers fixed-rate and adjustable-rate loans with terms of over 30 years. The Company offers fixed-rate residential real estate loans secured by one- to four-family residences with terms between 10 and 30 years. It also offers adjustable-rate mortgage loans. The Company’s commercial real estate loans include commercial construction and residential investment loan balances and interest income. The Bank’s total commercial real estate loans are approximately $287.8 million. The commercial real estate and residential investment loans are secured by apartment buildings and properties us! ed for business purposes, such as office buildings, industrial facilities and retail facilities. The Company’s total construction loans are over $56.6 million. The Company originates over $26.3 million in commercial and industrial loans. The Company has approximately $71.5 million in commercial and industrial loans. It offers automobile and recreational vehicle loans secured by new and used vehicles.
The Company invests in various types of liquid assets, including marketable equity securities, the United States Treasury obligations, securities of various government sponsored enterprises and municipal governments, deposits at the FHLB and certificates of deposit of federally insured institutions. Its investment portfolio consists of tax-exempt industrial revenue bonds, certificates of deposit, collateralized mortgage obligations and investment-grade marketable equity securities. The Company’s total investment securities are approximately $33.36 million.
Deposit Activities and Other Sources of Funds
The Company’s sources of funds are deposits, principal and interest payments on loans and investments, advances from the Federal Home Loan Bank of Boston (FHLB) and proceeds from loan sales. Its depositors are residents of the Commonwealth of Massachusetts. Deposits are attracted, by advertising and through its Website, from within its market areas through the offering of a selection of deposit instruments, including non-interest-bearing demand accounts (such as checking accounts), interest-bearing accounts (such as negotiable order of withdrawal (NOW) and money market deposit accounts), regular savings accounts (such as passbook accounts) and certificates of deposit. The Company’s total deposits are approximately $507.1 million.
The Company conducts its business activities through its subsidiaries, the Bank and Chicopee Funding Corporation. The Bank’s subsidiaries include CSB Colts, Inc., ! CSB Inves! tment Corp. and Cabot Realty L.L.C. CSB Colts, Inc. is engaged in buying, selling and holding securities on its own behalf and consists of tax-exempt industrial revenue bonds. CSB Investment Corp. is engaged in buying, selling and holding securities on its own behalf and consists of collateralized mortgage obligations and marketable equity securities. Cabot Realty L.L.C. is a liability company, which holds other real estate owned (OREO).
The Bank competes with Bank of America Corporation, Santander Bank, N.A., Citizens Financial Group, First Niagara Financial Group, Inc. and TD Bank, Inc.
- [By Shane Hupp]
Capital Bancorp (NASDAQ: CBNK) is one of 141 public companies in the “National commercial banks” industry, but how does it contrast to its rivals? We will compare Capital Bancorp to related businesses based on the strength of its analyst recommendations, profitability, valuation, earnings, dividends, risk and institutional ownership.
- [By Paul Ausick]
Capital Bancorp Inc. (NASDAQ: CBNK) raised $28 million selling 2.2 million shares priced at $12.50, the low end of the expected range. Shares got a 2% pop on the Friday IPO.
Top 10 Heal Care Stocks To Invest In Right Now: ConnectOne Bancorp, Inc.(CNOB)
ConnectOne Bancorp, Inc. operates as the bank holding company for ConnectOne Bank that provides various banking products and services. The company offers a range of deposit products, including personal and business checking accounts, retirement accounts, money market accounts, time and savings accounts, and NOW accounts. It also provides personal and commercial business loans on a secured and unsecured basis; revolving lines of credit; commercial mortgage loans; residential mortgages on primary and secondary residences; home equity loans; bridge loans; and other personal purpose loans. In addition, the company offers brokerage services, insurance and annuities, mutual funds, and financial planning services. Further, it provides credit cards, wire transfers, and safe deposit boxes; access to automated teller services; and Internet banking, treasury direct, ACH origination, lockbox, mobile banking, and remote deposit capture banking services. As of January 27, 2016, the company operated 21 banking offices. It serves small-to-medium sized businesses, high net worth individuals, professional practices, and consumer and retail customers. The company was formerly known as Center Bancorp, Inc. and changed its name to ConnectOne Bancorp, Inc. in July 2014. ConnectOne Bancorp, Inc. was founded in 1982 and is headquartered in Englewood Cliffs, New Jersey.
- [By Joseph Griffin]
ValuEngine cut shares of ConnectOne Bancorp (NASDAQ:CNOB) from a sell rating to a strong sell rating in a report published on Tuesday morning.
CNOB has been the subject of several other reports. Zacks Investment Research lowered shares of ConnectOne Bancorp from a hold rating to a sell rating in a report on Wednesday, February 13th. TheStreet upgraded shares of ConnectOne Bancorp from a c+ rating to a b- rating in a research report on Monday, February 25th. Finally, BidaskClub upgraded shares of ConnectOne Bancorp from a strong sell rating to a sell rating in a research report on Wednesday, January 2nd. Two research analysts have rated the stock with a sell rating, one has assigned a hold rating and one has issued a strong buy rating to the stock. ConnectOne Bancorp has an average rating of Hold and an average target price of $35.00.
- [By Max Byerly]
ConnectOne Bancorp Inc (NASDAQ:CNOB) has been assigned an average rating of “Buy” from the six ratings firms that are currently covering the stock, Marketbeat reports. One analyst has rated the stock with a sell rating, two have issued a hold rating, two have given a buy rating and one has issued a strong buy rating on the company. The average 1 year target price among analysts that have issued a report on the stock in the last year is $33.50.
- [By Ethan Ryder]
Media headlines about Center Bancorp (NASDAQ:CNOB) have trended somewhat positive on Tuesday, according to Accern. The research firm ranks the sentiment of press coverage by analyzing more than 20 million blog and news sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Center Bancorp earned a news impact score of 0.09 on Accern’s scale. Accern also assigned press coverage about the financial services provider an impact score of 47.8586921520597 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the stock’s share price in the next few days.
Top 10 Heal Care Stocks To Invest In Right Now: Penumbra, Inc.(PEN)
Penumbra, Inc. designs, develops, manufactures, and markets medical devices in the United States, Europe, Canada, Australia, Japan, and internationally. The company offers neurovascular access systems under the Neuron, Neuron MAX, Select, BENCHMARK, DDC, PXSLIM, and Velocity brands; aspiration based thrombectomy systems and accessory devices under the Penumbra System brand; and stent retriever for mechanical thrombectomy under the 3D brand. It also provides neurovascular embolization coiling systems to treat patients with various sizes of aneurysms and other neurovascular lesions under the Penumbra Coil 400 and Penumbra SMART Coil brands; and neurovascular stents for stent-assisted coiling in large and wide-neck aneurysms under the LIBERTY Stent brand. In addition, the company offers neurosurgical tools for the removal of tissue and fluids under the Apollo System brand; and detachable embolic coil systems for peripheral embolization under the RUBY Coil brand, as well as Lantern, a microcatheter for the delivery of detachable coils and occlusion devices. Further, it provides detachable, microcatheter-deliverable occlusion devices under the POD (penumbra occlusion device) brand; and aspiration-based thrombectomy systems for peripheral applications under the Indigo System brand, as well as POD Packing Coil, a device for use with RUBY Coil and POD for vessel occlusion. The company sells its products through direct sales organizations and distributors to hospitals in neuro and peripheral vascular markets. Penumbra, Inc. was founded in 2004 and is headquartered in Alameda, California.
- [By Motley Fool Transcribers]
Penumbra Inc (NYSE:PEN)Q42018 Earnings Conference CallFeb. 05, 2019, 4:30 p.m. ET
Prepared Remarks Questions and Answers Call Participants
- [By Ethan Ryder]
Mission Wealth Management LP decreased its stake in shares of Penumbra Inc (NYSE:PEN) by 8.1% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 11,723 shares of the company’s stock after selling 1,040 shares during the period. Mission Wealth Management LP’s holdings in Penumbra were worth $1,433,000 as of its most recent SEC filing.
Top 10 Heal Care Stocks To Invest In Right Now: Sarepta Therapeutics, Inc.(SRPT)
We are a biopharmaceutical company focused on the discovery and development of unique RNA-targeted therapeutics for the treatment of rare, infectious and other diseases. Applying our proprietary, highly-differentiated and innovative platform technologies, we are able to target a broad range of diseases and disorders through distinct RNA-targeted mechanisms of action. We are primarily focused on rapidly advancing the development of our potentially disease-modifying DMD drug candidates, including our lead DMD product candidate, eteplirsen, designed to skip exon 51. On August 25, 2015, we announced the FDA filing of our NDA for eteplirsen for the treatment of DMD amenable to exon 51 skipping. The FDA postponed the Advisory Committee meeting for the review of the eteplirsen NDA previously scheduled for January 22, 2016 due to severe weather. Advisors’ Opinion:
- [By ]
Some of my readers may know Sarepta (Nasdaq: SRPT) well. This $9 billion gene-therapy company already has an FDA-approved product. Exondys 51, the first-ever FDA-approved treatment for a rare but deadly genetic disease called Duchenne muscular dystrophy (DMD), is already on the market. And just last month, the FDA granted priority review for SRPT’s second treatment for DMD, golodirsen, for DMD patients with a different genetic mutation.
- [By Dan Caplinger]
Wednesday was a bad day on Wall Street, as most major indexes finished lower. Small-cap stocks were hit harder than their large-cap counterparts, due in part to readings on the U.S. economy that signaled the possibility of a slowdown in the future. Moreover, downward pressure from some high-profile players weighed on overall market sentiment. NIO (NYSE:NIO), Brown-Forman (NYSE:BF-A) (NYSE:BF-B), and Sarepta Therapeutics (NASDAQ:SRPT) were among the worst performers. Here’s why they did so poorly.
Top 10 Heal Care Stocks To Invest In Right Now: John Hancock Tax-Advantaged Global Shareholder Yield Fund(HTY)
John Hancock Tax-Advantaged Global Shareholder Yield Fund (the Fund) is a diversified, closed-end management investment company. The Funds investment objective is to provide a high level of total return consisting of a high level of current income and gains and long term capital appreciation. The Fund will seek to achieve favorable after-tax returns for its shareholders by seeking to minimize the federal income tax consequences on income and gains generated by the Fund. Under normal market condition, the Fund will invest at least 80% of its total assets in a diversified portfolio of dividend-paying stocks of issuers located around the world. The Fund also intends to write call options on a variety of both U.S. and non-U.S. broad-based indices. It invests in sectors, such as utilities, telecommunication services, consumer staples, financials, industrials, energy, healthcare, information technology, consumer discretionary and materials. The Funds investment advisor is John Hancock Advisers, LLC, a wholly owned indirect subsidiary of Manulife Financial Corporation. Its sub-advisors are Epoch Investment Partners, Inc. and Analytic Investors, LLC.
- [By Shane Hupp]
John Hancock Tax-Advntgd Glbl SH Yld Fd (NYSE:HTY) declared a quarterly dividend on Thursday, August 23rd, Wall Street Journal reports. Shareholders of record on Friday, September 14th will be paid a dividend of 0.16 per share on Friday, September 28th. This represents a $0.64 annualized dividend and a yield of 7.68%. The ex-dividend date is Thursday, September 13th.
Top 10 Heal Care Stocks To Invest In Right Now: Telefonica SA(TEF)
Telefonica, S.A. provides fixed and mobile telephony services primarily in Spain, rest of Europe, and Latin America. Its fixed telecommunication services include PSTN lines; ISDN accesses; public telephone; local, domestic, and international long distance and fixed-to-mobile communications; corporate communications; video telephony; supplementary and business-oriented value-added services; network services; leasing and sale of handset equipment; and telephony information services. The company?s Internet and broadband multimedia services comprise Internet service provider service; portal and network services; retail and wholesale broadband access; narrowband switched access to Internet; naked ADSL, a broadband connection; residential-oriented value-added services; companies-oriented value-added services; television services, such as IPTV, cable television, and satellite television; and Fiber to the Home, a service for high speed Internet access and digital video recording. Its data and business-solutions services principally include leased lines; virtual private network services; fiber optics services; the provision of hosting and application; outsourcing and consultancy services; desktop services; and system integration and professional services. The company?s wholesale services for telecommunication operators primarily comprise domestic interconnection services; international wholesale services; leased lines for other operators? network deployment; local loop leasing under the unbundled local loop regulation framework; and bit stream services. It also offers various mobile and related services and products that include mobile voice services, value added services, mobile data and Internet services, wholesale services, corporate services, roaming, fixed wireless, and trunking and paging services. The company has a strategic alliance with China Unicom (Hong Kong) Limited. Telefonica, S.A. was founded in 1924 and is headquartered in Madrid, Spai n.
- [By Logan Wallace]
Telefonica (NYSE:TEF) and TELE2 AB/ADR (OTCMKTS:TLTZY) are both utilities companies, but which is the superior stock? We will compare the two businesses based on the strength of their risk, earnings, profitability, institutional ownership, dividends, analyst recommendations and valuation.
- [By Joseph Griffin]
Telefonica S.A. (NYSE:TEF) has been given an average rating of “Hold” by the fifteen analysts that are currently covering the stock, Marketbeat Ratings reports. Three research analysts have rated the stock with a sell rating, five have assigned a hold rating and six have issued a buy rating on the company.
Top 10 Heal Care Stocks To Invest In Right Now: Independence Realty Trust, Inc.(IRT)
Independence Realty Trust, Inc., incorporated on March 26, 2009, is an externally managed and advised apartment real estate investment trust (REIT). The Company’s business consists of owning, managing, operating, leasing, acquiring, developing, investing in, and disposing of real estate assets. It owns and operates a portfolio of garden style and mid-rise apartment communities in the Southeastern United States. The Company’s portfolio consists of approximately 50 apartment properties containing an aggregate of over 13,700 apartment units. The Company’s portfolio has an average occupancy of approximately 93.6%. The Company conducts its business through a traditional umbrella partnership REIT (UPREIT) structure in which its properties are owned by its operating partnership, Independence Realty Operating Partnership, LP (IROP), directly or through subsidiaries. The Company is the sole general partner of IROP.
The Company’s apartment properties include Belle Creek, Copper Mill, Crestmont, Cumberland Glen, Heritage Trace, Tresa at Arrowhead, Centrepoint, Runaway Bay, Berkshire Square, The Crossings, Reserve at Eagle Ridge, Windrush, Heritage Park, Raindance, Augusta, Invitational, King’s Landing, Carrington Park, Arbors at the Reservoir, Walnut Hill, Lenoxplace, Stonebridge Crossing, Bennington Pond, Prospect Park, Brookside, Jamestown, Meadows, Oxmoor, Stonebridge at the Ranch, Iron Rock Ranch, Bayview Club, Arbors River Oaks, Aston, Avenues at Craig Ranch, Bridge Pointe, Creekstone at RTP, Fountains Southend, Fox Trails, Lakeshore on the Hill, Millenia 700, Miller Creek at German Town, Pointe at Canyon Ridge, St James at Goose Creek, Talison Row at Daniel Island, The Aventine Greenville, Trails at Signal Mountain, Vue at Knoll Trail, Waterstone at Brier Creek, Waterstone Big Creek and Westmont Commons. The Company is managed by a subsidiary of RAIT Financial Trust (RAIT), a real estate company organized as an internally managed REIT.
- [By Joseph Griffin]
BlackRock Inc. grew its position in Independence Realty Trust Inc (NYSE:IRT) by 17.1% during the 2nd quarter, HoldingsChannel.com reports. The fund owned 14,596,051 shares of the real estate investment trust’s stock after purchasing an additional 2,128,304 shares during the period. BlackRock Inc. owned about 0.17% of Independence Realty Trust worth $150,484,000 at the end of the most recent quarter.
- [By Ethan Ryder]
Independence Realty Trust Inc (NYSE:IRT) has been given a consensus rating of “Buy” by the nine ratings firms that are presently covering the stock, Marketbeat reports. One research analyst has rated the stock with a sell rating, two have issued a hold rating and five have assigned a buy rating to the company. The average 12-month target price among brokerages that have issued ratings on the stock in the last year is $10.75.
- [By Max Byerly]
Get a free copy of the Zacks research report on Independence Realty Trust (IRT)
For more information about research offerings from Zacks Investment Research, visit Zacks.com